Structural Heart > TAVI PortfolioACURATE neo Aortic Valve System

Lean TAVI Procedures with ACURATE neo1

Watch Prof. R. Kharbanda (Oxford, UK) discussing how minimalist TAVI with ACURATE neo results in fewer instances of damage to the conduction system, reduced need for permanent pacemaker and subsequently leads to early discharge which he highlights is “good for the patients and good for the families as well”.
If you can reduce complications and if you don’t need a pacemaker, patients can be dicharged early.
 
R. Kharbanda
 

TAVI Program Efficiency

Lean procedures with low complication rates enable safe, early discharge and optimized hospital resources.1
 


45%

Patients Discharged within 2 Days1

with
ACURATE neo
vs 31% with Evolut R

Download data
Length of Stay (LoS)

60%

Safe Next Day Discharge2

with
ACURATE neo
vs 55% with Sapien 3

Download data
Next Day Discharge (NDD)


Procedural Efficiency3

Predictable Deployment

Predictable Deployment and Hemodynamic Stability

The unique, Predictable Top-down Deployment ensures efficiency by providing hemodynamic stability and precise placement during deployment.

Preserved Coronary Perfusion & Future Access

Unique valve design with upper crowns and large open stabilization arches provide coronary clearance and preserved access for future interventions.


PROGRESS PVL
Low, core-lab adjudicated PVL rates and Excellent Hemodynamic Performance4

Low moderate or greater PVL Rates that improved through 1 year

 

PVL, Paired Analysis

(N = 209, core-lab adjudicated)


Excellent Hemodynamic Performance

 


Hemodynamic Performance

(mmHg/cm2, core-lab adjudicated)

Strong VARC-2 Clinical Outcomes

Primary Effectiveness Endpoint Components at 1 Year

Enhance your Clinical Expertise with the
ACURATE neo Aortic Valve System

Top